These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32375305)

  • 21. Roles of Non-coding RNAs in Respiratory Syncytial Virus (RSV) Infection.
    Tripp RA; Bakre AA
    Curr Top Microbiol Immunol; 2018; 419():215-241. PubMed ID: 28646339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of mucosal and cellular immune response in mice by vaccination with respiratory syncytial virus DNA encapsulated with transfersome.
    Xu J; Ding Y; Yang Y
    Viral Immunol; 2008 Dec; 21(4):483-9. PubMed ID: 19115938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.
    Canedo-Marroquín G; Acevedo-Acevedo O; Rey-Jurado E; Saavedra JM; Lay MK; Bueno SM; Riedel CA; Kalergis AM
    Front Cell Infect Microbiol; 2017; 7():367. PubMed ID: 28861397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.
    González AE; Lay MK; Jara EL; Espinoza JA; Gómez RS; Soto J; Rivera CA; Abarca K; Bueno SM; Riedel CA; Kalergis AM
    Virulence; 2017 Aug; 8(6):685-704. PubMed ID: 27911218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chitosan alters inactivated respiratory syncytial virus vaccine elicited immune responses without affecting lung histopathology in mice.
    Muralidharan A; Russell MS; Larocque L; Gravel C; Sauvé S; Chen Z; Li C; Chen W; Cyr T; Rosu-Myles M; Wang L; Li X
    Vaccine; 2019 Jul; 37(30):4031-4039. PubMed ID: 31186190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8
    Lee JY; Chang J
    J Microbiol; 2017 Nov; 55(11):900-908. PubMed ID: 29076066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immune response to respiratory syncytial virus infection: friend or foe?
    Welliver RC
    Clin Rev Allergy Immunol; 2008 Apr; 34(2):163-73. PubMed ID: 17985249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respiratory syncytial virus infection and immunity.
    González PA; Bueno SM; Carreño LJ; Riedel CA; Kalergis AM
    Rev Med Virol; 2012 Jul; 22(4):230-44. PubMed ID: 22290692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model.
    Blanco JCG; Pletneva LM; McGinnes-Cullen L; Otoa RO; Patel MC; Fernando LR; Boukhvalova MS; Morrison TG
    Nat Commun; 2018 May; 9(1):1904. PubMed ID: 29765035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clara cell secretory protein modulates lung inflammatory and immune responses to respiratory syncytial virus infection.
    Wang SZ; Rosenberger CL; Bao YX; Stark JM; Harrod KS
    J Immunol; 2003 Jul; 171(2):1051-60. PubMed ID: 12847279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age predicts cytokine kinetics and innate immune cell activation following intranasal delivery of IFNγ and GM-CSF in a mouse model of RSV infection.
    Eichinger KM; Resetar E; Orend J; Anderson K; Empey KM
    Cytokine; 2017 Sep; 97():25-37. PubMed ID: 28558308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
    McGinnes Cullen L; Schmidt MR; Morrison TG
    J Virol; 2019 May; 93(9):. PubMed ID: 30760576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impairment of the CD8+ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or route of infection.
    DiNapoli JM; Murphy BR; Collins PL; Bukreyev A
    Virol J; 2008 Sep; 5():105. PubMed ID: 18816384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CpG in Combination with an Inhibitor of Notch Signaling Suppresses Formalin-Inactivated Respiratory Syncytial Virus-Enhanced Airway Hyperresponsiveness and Inflammation by Inhibiting Th17 Memory Responses and Promoting Tissue-Resident Memory Cells in Lungs.
    Zhang L; Li H; Hai Y; Yin W; Li W; Zheng B; Du X; Li N; Zhang Z; Deng Y; Zeng R; Wei L
    J Virol; 2017 May; 91(10):. PubMed ID: 28275186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-viral atopic airway disease: pathogenesis and potential avenues for intervention.
    Hussain SA; Mejias A; Ramilo O; Peeples ME; Grayson MH
    Expert Rev Clin Immunol; 2019 Jan; 15(1):49-58. PubMed ID: 30370798
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development.
    Garg R; Shrivastava P; van Drunen Littel-van den Hurk S
    Expert Rev Vaccines; 2012 Dec; 11(12):1441-57. PubMed ID: 23252388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of respiratory syncytial virus (RSV) antigen in the lungs of guinea pigs 6 weeks after experimental infection and despite of the production of neutralizing antibodies.
    Streckert HJ; Philippou S; Riedel F
    Arch Virol; 1996; 141(3-4):401-10. PubMed ID: 8645083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent.
    Tekkanat KK; Maassab HF; Cho DS; Lai JJ; John A; Berlin A; Kaplan MH; Lukacs NW
    J Immunol; 2001 Mar; 166(5):3542-8. PubMed ID: 11207314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of respiratory syncytial virus infection on dendritic cells and cysteinyl leukotrienes in lung tissues of a murine model of asthma.
    Matsuse H; Hirose H; Tsuchida T; Fukahori S; Fukushima C; Mizuta Y; Kohno S
    Allergol Int; 2007 Jun; 56(2):165-9. PubMed ID: 17460444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.